InvestorsHub Logo

James salmon

10/17/19 6:47 PM

#47285 RE: James salmon #47284

Although that was on Tuesday but seems to be getting posted now;

OncoSec Medical (NASDAQ:ONCS) was upgraded by Zacks Investment Research from a “hold” rating to a “buy” rating in a research note issued to investors on Tuesday, Zacks.com reports.

ignatiusrielly35

10/17/19 7:13 PM

#47286 RE: James salmon #47284

Ah. Still, not much volume.